1,721,364 research outputs found
Qualità di vita nei pazienti con poliuria notturna ed enuresi: considerazioni concettuali e metodologiche
Is Simple Enucleation a Minimal Partial Nephrectomy Responding to the EAU Guidelines' Recommendations?
Editorial Material (No abstract available
Re: Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of Medicare-age men
Medical treatment of LUTS/BPH
Several drug therapies are available for male patients with bothersome lower urinary tract symptoms. Monotherapy with α-blockers is a commonly used and effective treatment to quickly improve LUTS, quality of life, and Q max. The main differences among the drugs are in the profile of adverse events [AEs], with cardiovascular AEs less prevalent with uroselective drugs (and especially with the novel silodosin, which is the compound with the highest selectivity). Conversely, ejaculatory dysfunction is less prevalent with nonselective drugs. 5α-reductase inhibitors [5-ARIs], alone or in combination with α-blockers, might be offered to men who have moderate to severe LUTS and an enlarged prostate to reduce the risk of urinary retention and prostate-related surgery. Those patients with prevalent storage LUTS may have benefited from anticholinergics. The risk of urinary retention with that category of drugs is minimal if patients with a higher risk of bladder outlet obstruction are avoided (e.g., those with PVR >200 mL, Q max <5 mL/s, or history of prior retention). Finally, tadalafil 5 mg is effective in improving symptoms in patients with LUTS, with or without concomitant erectile dysfunction
Re: Health Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial: A Multi-institutional Randomized Trial Comparing Robot Versus Open Radical Cystectomy
Evidence-based medicine: the supporting pillar of trial registration.
Evidence-based Medicine: The Supporting Pillar of Trial Registratio
Editorial comment on: Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial.
No abstract availabl
- …
